Literature DB >> 32790950

Liver failure and x-linked immunodeficiency type 47.

Alexis J Gumm1, Donald G Basel2, Pooja Thakrar3, Mariko Suchi4, Grzegorz Telega1.   

Abstract

Patients with defects in the ATP6AP1 gene have rarely been described. ATP6AP1-related disorders are a subtype of CDG, which result in enzyme deficiencies affecting multiple organ systems ranging from mild to life-threatening. Of the 13 patients described, all had hepatopathy, but this is the first case to be successfully transplanted. We describe two brothers who developed hyperbilirubinemia shortly after birth and progressed to liver failure, case 1 by 12 months of age, with successful transplant 2 years later, and case 2 by 4 months of age, who passed away while awaiting liver transplant. Both boys were found to have a new variant in the ATP6AP1 gene: c.932/p.Leu311Gln. Although the identified ATP6AP1 gene variant was classified as unknown significance at the time, both children's phenotypes fit with what has been described for ATP6AP1-related disorders. Therefore, this result appears to have been diagnostic for both boys. This rare type of CDG, X-linked immunodeficiency type 47 (OMIM #300972), particularly in patients who progress to liver failure requiring transplant, should be included on the differential of liver failure in infants and toddlers, and its gene should be added to the diagnostic workup for such cases.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  ATP6AP1; c.932/p.Leu311Gln; glycosylation; liver failure; x-linked immunodeficiency

Year:  2020        PMID: 32790950     DOI: 10.1111/petr.13808

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

1.  Expanding the phenotype of ATP6AP1 deficiency.

Authors:  Elaine M Pereira; Vaidehi Jobanputra; Subit Barua; Sara Berger
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-06-22

2.  Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review.

Authors:  Rossella Colantuono; Elisa D'Acunto; Daniela Melis; Pietro Vajro; Hudson H Freeze; Claudia Mandato
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-10-01       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.